Ptc Therapeutics (PTCT) Return on Sales: 2013-2025
Historic Return on Sales for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to 0.28%.
- Ptc Therapeutics' Return on Sales rose 87.00% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 87.00%. This contributed to the annual value of -0.78% for FY2024, which is 1.00% down from last year.
- Per Ptc Therapeutics' latest filing, its Return on Sales stood at 0.28% for Q3 2025, which was up 32.34% from 0.21% recorded in Q2 2025.
- Ptc Therapeutics' Return on Sales' 5-year high stood at 0.28% during Q3 2025, with a 5-year trough of -1.17% in Q1 2021.
- Moreover, its 3-year median value for Return on Sales was -0.70% (2024), whereas its average is -0.44%.
- Per our database at Business Quant, Ptc Therapeutics' Return on Sales declined by 26bps in 2021 and then spiked by 91bps in 2025.
- Quarterly analysis of 5 years shows Ptc Therapeutics' Return on Sales stood at -0.97% in 2021, then increased by 17bps to -0.81% in 2022, then rose by 4bps to -0.76% in 2023, then grew by 9bps to -0.67% in 2024, then spiked by 87bps to 0.28% in 2025.
- Its last three reported values are 0.28% in Q3 2025, 0.21% for Q2 2025, and 0.19% during Q1 2025.